Skip to main content
Premium Trial:

Request an Annual Quote

Eric Neumann, Paul Grayson, Mark Zoller, Lubert Stryer, Saiid Zarrabian.

Premium

Eric Neumann, who recently left his post as vice president of life science informatics at 3rd Millennium of Cambridge, Mass., has been appointed vice president of bioinformatics at Beyond Genomics, also of Cambridge.

In this newly formed position, Neumann will handle all the informatics needs of the company, including genomics, proteomics, functional genomics, and metabolomics. He is currently building the company’s informatics team.

Senomyx of La Jolla, Calif., has appointed Paul Grayson chairman of the board and promoted Mark Zoller to the position of CSO.

Grayson, who is CEO of the company, and Zoller, who is vice president of research, will be replacing Lubert Stryer in his roles as chairman and CSO.

Earlier this month, Senomyx announced that Saiid Zarrabian, who resigned as chief operating officer at Pharmacopeia in December, had been appointed president and COO of Senomyx.

Zarrabian replaced Grayson in his previous role as president.

Filed under

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.